NCT06172296 2026-04-14
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Recruiting
National Cancer Institute (NCI)
NRG Oncology
NRG Oncology
Jonsson Comprehensive Cancer Center
NRG Oncology
Children's Oncology Group
Children's Oncology Group
NRG Oncology
Mayo Clinic
Children's Oncology Group
Children's Oncology Group
NRG Oncology